Literature DB >> 1330400

Analysis of factors limiting maximal exercise performance in cystic fibrosis.

L C Lands1, G J Heigenhauser, N L Jones.   

Abstract

1. Maximal exercise capacity in cystic fibrosis is influenced by both pulmonary and nutritional factors: lung disease by limiting maximal achievable ventilation, and malnutrition through a loss of muscle mass. The associated reduction in everyday activities may result in peripheral muscle deconditioning. 2. We studied 14 stable patients with cystic fibrosis (six males, eight females) and 14 healthy control subjects (seven males, seven females) in order to assess the influence of these factors on exercise performance. Subjects underwent anthropometry to estimate muscle mass, spirometry to assess ventilatory capacity, a 30 s sprint on an isokinetic cycle ergometer to assess maximal leg muscle performance, and progressive cycle ergometry to assess overall exercise capacity. 3. Compared with control subjects, the patients with cystic fibrosis were of similar age and height but weighed proportionately less [% ideal weight (mean +/- SD): 94.3 +/- 9.64 versus 109.5 +/- 11.82] and showed evidence of airflow limitation [forced expiratory volume in 1.0 s (FEV1.0) 72.5 +/- 24.78 versus 112.6 +/- 14.25% of predicted]. 4. The patients with cystic fibrosis did less absolute (5.1 +/- 1.89 versus 7.3 +/- 1.97 kJ) but similar relative maximal (11.5 +/- 3.41 versus 13.1 +/- 3.55 kJ/kg lean body mass) sprint work. During progressive exercise, the group with cystic fibrosis achieved lower absolute [maximal O2 consumption (VO2max.) 1.8 +/- 0.527 versus 3.0 +/- 0.655 litres/min] and relative (VO2max./kg lean body mass: 40.5 +/- 9.23 versus 53.0 +/- 11.62 ml min-1 kg-1) work levels.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Year:  1992        PMID: 1330400     DOI: 10.1042/cs0830391

Source DB:  PubMed          Journal:  Clin Sci (Lond)        ISSN: 0143-5221            Impact factor:   6.124


  25 in total

1.  Cardiorespiratory and sensory responses to exercise in adults with mild cystic fibrosis.

Authors:  Bradley S Quon; Sabrina S Wilkie; Yannick Molgat-Seon; Michele R Schaeffer; Andrew H Ramsook; Pearce G Wilcox; Jordan A Guenette
Journal:  J Appl Physiol (1985)       Date:  2015-10-01

2.  Individualised unsupervised exercise training in adults with cystic fibrosis: a 1 year randomised controlled trial.

Authors:  A J Moorcroft; M E Dodd; J Morris; A K Webb
Journal:  Thorax       Date:  2004-12       Impact factor: 9.139

Review 3.  Urinary incontinence in cystic fibrosis.

Authors:  Mary E Dodd; Hannah Langman
Journal:  J R Soc Med       Date:  2005       Impact factor: 5.344

4.  Peak oxygen uptake and mortality in children with cystic fibrosis.

Authors:  P Pianosi; J Leblanc; A Almudevar
Journal:  Thorax       Date:  2005-01       Impact factor: 9.139

5.  Research in exercise physiology and dyspnea at McMaster University.

Authors:  Norman L Jones
Journal:  Can Respir J       Date:  2007-10       Impact factor: 2.409

6.  Exercise testing in cystic fibrosis: why (and how)?

Authors:  D S Urquhart
Journal:  J R Soc Med       Date:  2011-07       Impact factor: 5.344

Review 7.  Exercise recommendations for individuals with cystic fibrosis.

Authors:  S R Boas
Journal:  Sports Med       Date:  1997-07       Impact factor: 11.136

8.  Gender differences in habitual activity in children with cystic fibrosis.

Authors:  H C Selvadurai; C J Blimkie; P J Cooper; C M Mellis; P P Van Asperen
Journal:  Arch Dis Child       Date:  2004-10       Impact factor: 3.791

9.  Exercise testing in patients with cystic fibrosis-importance of ventilatory parameters.

Authors:  Matthew A Tucker; Nichole Lee; Paula Rodriguez-Miguelez; Jacob Looney; Reva H Crandall; Caralee Forseen; Kathleen T McKie; Ryan A Harris
Journal:  Eur J Appl Physiol       Date:  2018-10-24       Impact factor: 3.078

10.  Exercise training in children and adolescents with cystic fibrosis: theory into practice.

Authors:  Craig A Williams; Christian Benden; Daniel Stevens; Thomas Radtke
Journal:  Int J Pediatr       Date:  2010-09-19
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.